Evidence map›Paper›PMID 32425421›Full record

ArticleJournal of orthopaedics

The location of the fracture determines the better solution, osteosynthesis or revision, in periprosthetic femoral fractures.

Yoshihiko Okudera, Hiroaki Kijima, Shin Yamada, Natsuo Konishi, Hitoshi Kubota, Hiroshi Tazawa, Takayuki Tani, Norio Suzuki, Keiji Kamo, Masashi Fujii and 7 more

Abstract read
In one paragraph

Article in Journal of orthopaedics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. [Effectiveness of shape memory alloy embracing device in treatment of Vancouver B2 periprosthetic femoral fracture].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yoshihiko OkuderaAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Hiroaki KijimaDepartment of Orthopedic Surgery, Akita University Graduate School of Medicine, Hondo 1-1-1, Akita, 010-8543, Japan.
Shin YamadaAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Natsuo KonishiAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Hitoshi KubotaAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Hiroshi TazawaAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Takayuki TaniAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Norio SuzukiAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Keiji KamoAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Masashi FujiiDepartment of Orthopedic Surgery, Akita University Graduate School of Medicine, Hondo 1-1-1, Akita, 010-8543, Japan.
Ken SasakiAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Tetsuya KawanoDepartment of Orthopedic Surgery, Akita University Graduate School of Medicine, Hondo 1-1-1, Akita, 010-8543, Japan.
Yosuke IwamotoAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Itsuki NagahataAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Takanori MiuraAkita Hip Research Group (AHRG), Hondo 1-1-1, Akita, 010-8543, Japan.
Naohisa MiyakoshiDepartment of Orthopedic Surgery, Akita University Graduate School of Medicine, Hondo 1-1-1, Akita, 010-8543, Japan.
Yoichi ShimadaDepartment of Orthopedic Surgery, Akita University Graduate School of Medicine, Hondo 1-1-1, Akita, 010-8543, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePeriprosthetic femoral fractures are difficult to treat, but few reports have included many periprosthetic femoral fractures. The purpose of this study was to investigate the trends and characteristics of a large number of periprosthetic femoral fractures and to determine the best treatment strategy for such fractures.

methodsThe fracture type according to the Vancouver classification, the stem fixation style of previous surgery, the elapsed time from previous surgery, and the treatment method for periprosthetic fractures of 51 patients with periprosthetic femoral fractures who were seen between 2006 and 2018 were investigated.

resultsThe types of fractures according to the Vancouver classification were: type A 5.9%, type B1 47%, type B2 20%, type B3 2.0%, and type C 25%. Of the previous surgeries, 76% were cementless fixation, and 24% were cemented fixation. The mean duration from previous surgery to periprosthetic femoral fracture was 8 years and 7 months (1-358 months), and injury within 1 year from previous surgery was most commonly observed (24%). As treatment for periprosthetic femoral fractures, conservative treatment was performed in 8%, and surgery was performed in 92%. Of the surgery cases, 53% underwent osteosynthesis, and 39% underwent revision surgery. Of type B1 surgery cases, 58% were treated with osteosynthesis, and 33% underwent revision surgery, although type B1 had no stem loosening.

conclusionMany periprosthetic femoral fractures occurred within 1 year after the previous surgery. Therefore, preventive measures for periprosthetic femoral fractures should be started immediately after total hip replacement. In addition, revision surgery was performed even if the stem was not loosened in cases where it was judged that sufficient osteosynthesis could not be performed.

Indexed as

Femoral neck replacementPeriprosthetic femoral fractureRevision arthroplastyTotal hip replacementVancouver classification

Identifiers

PMID32425421
PMCPMC7225599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.